Sydnexis to Present Three Abstracts at ARVO 2025 Annual Meeting
01 May 2025 //
BUSINESSWIRE
Sydnexis gets positive CHMP opinion in Europe for SYD-101
01 Apr 2025 //
BUSINESSWIRE
Sydnexis: FDA Accepts SYD-101 NDA for Pediatric Myopia
11 Mar 2025 //
BUSINESSWIRE
Sydnexis Appoints Perry Sternberg CEO
16 Jul 2024 //
CONTRACT PHARMA